Neuroimaging webinars powered by EATRIS and NeurATRIS

We are pleased to announce that EATRIS and NEURATRIS are launching a series of webinars on Neuroimaging in November of this year. The series will cover the usage of CEST-MRI, optical  imaging and PET imaging in neurodegenerative diseases and their potential application in translational medicine. These webinars will be brought to you by experts in the field.

All webinars will take place from 14:00-15:00 CET and are free of charge. The neuroimaging webinars include an audience Q&A session during which attendees can ask questions at the end of the lecture. Please note that all webinars will be recorded and available for later viewing.

Why should you join ?

  • Learn about the cutting-edge methodological and technical developments in neuroimaging

  • Discover applications in translational research

  • Hear and share with experts in their field

  • Identify state-of-the-art facilities for your future projects, both with academia and industry


SESSION 1: NOVEMBER 6TH 14.00 – 15.00 (CET)

Translational Metabolic Imaging using CEST MRI in Neurodegenerative Diseases by Dr. Julien Flament

Chemical Exchange Saturation Transfer (CEST) imaging has emerged over the past decade as a new and innovative MRI contrast method, specifically designed for molecular imaging. CEST offers the possibility to detect a large variety of metabolites including glutamate, glucose, or creatine. This confers to CEST the potential to provide valuable clues about various pathological features in a single experiment.


Please click here for more information and registration to the webinar.


SESSION 2: NOVEMBER 20TH 14.00 – 15.00 (CET)

Optical imaging tools for brain cells by Basile Gurchenkov

In this webinar, Basile Gurchenkov will address how to choose the most suitable type of microscope for your neurological mechanisms and cells of interest. He will share his insights about multiphotonic, light-sheet, confocal, transmission electron microscopes and spinning disks. 


Please click here for more information and registration to the webinar.


SESSION 3: NOVEMBER 27TH 14.00 – 15.00 (CET)

PET imaging to investigate neurodegenerative diseases by Sonia Lavisse and Nadja van Camp

Accurate and prompt diagnosis is vital to accommodate differential prognostic and brain disease management approaches, and to assess the efficacy of experimental therapeutic interventions in clinical trials. PET imaging plays a pivotal role in this regard by providing an in vivo opportunity to visualize the neuroanatomical and functional signatures of these disorders, as well as identifying disease-specific biomarkers of the underlying neurodegenerative processes.

This presentation will provide a brief introduction of the PET modality followed by an overview of the prominent preclinical and clinical application of this well-established and promising imaging tool in neurodegenerative diseases.


Please click here for more information and registration to the webinar.